ID   NPT2A_HUMAN             Reviewed;         639 AA.
AC   Q06495; B4DPE3;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   10-MAY-2017, entry version 154.
DE   RecName: Full=Sodium-dependent phosphate transport protein 2A;
DE            Short=Sodium-phosphate transport protein 2A;
DE   AltName: Full=Na(+)-dependent phosphate cotransporter 2A;
DE   AltName: Full=NaPi-3 {ECO:0000303|PubMed:8327470};
DE   AltName: Full=Sodium/phosphate cotransporter 2A;
DE            Short=Na(+)/Pi cotransporter 2A;
DE            Short=NaPi-2a;
DE   AltName: Full=Solute carrier family 34 member 1 {ECO:0000312|HGNC:HGNC:11019};
GN   Name=SLC34A1 {ECO:0000312|HGNC:HGNC:11019};
GN   Synonyms=NPT2 {ECO:0000250|UniProtKB:Q60825},
GN   SLC17A2 {ECO:0000312|HGNC:HGNC:11019};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Kidney;
RX   PubMed=8327470; DOI=10.1073/pnas.90.13.5979;
RA   Magagnin S., Werner A., Markovich D., Sorribas V., Stange G.,
RA   Biber J., Murer H.;
RT   "Expression cloning of human and rat renal cortex Na/Pi cotransport.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:5979-5983(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   INTERACTION WITH SLC9A3R1.
RX   PubMed=22506049; DOI=10.1371/journal.pone.0034764;
RA   Courbebaisse M., Leroy C., Bakouh N., Salaun C., Beck L.,
RA   Grandchamp B., Planelles G., Hall R.A., Friedlander G., Prie D.;
RT   "A new human NHERF1 mutation decreases renal phosphate transporter
RT   NPT2a expression by a PTH-independent mechanism.";
RL   PLoS ONE 7:E34764-E34764(2012).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, INVOLVEMENT IN HCINF2, VARIANTS HCINF2
RP   91-VAL--ALA-97 DEL; ALA-153; VAL-153; PRO-155; TRP-215; GLY-336;
RP   GLU-408 AND ARG-488, AND CHARACTERIZATION OF VARIANTS HCINF2
RP   91-VAL--ALA-97 DEL; ALA-153; VAL-153; PRO-155; GLY-336; GLU-408 AND
RP   ARG-488.
RX   PubMed=26047794; DOI=10.1681/ASN.2014101025;
RA   Schlingmann K.P., Ruminska J., Kaufmann M., Dursun I., Patti M.,
RA   Kranz B., Pronicka E., Ciara E., Akcay T., Bulus D., Cornelissen E.A.,
RA   Gawlik A., Sikora P., Patzer L., Galiano M., Boyadzhiev V., Dumic M.,
RA   Vivante A., Kleta R., Dekel B., Levtchenko E., Bindels R.J., Rust S.,
RA   Forster I.C., Hernando N., Jones G., Wagner C.A., Konrad M.;
RT   "Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate
RT   cotransporter 2A cause idiopathic infantile hypercalcemia.";
RL   J. Am. Soc. Nephrol. 27:604-614(2016).
RN   [6]
RP   VARIANTS NPHLOP1 PHE-48 AND MET-147, AND CHARACTERIZATION OF VARIANTS
RP   NPHLOP1 PHE-48 AND MET-147.
RX   PubMed=12324554; DOI=10.1056/NEJMoa020028;
RA   Prie D., Huart V., Bakouh N., Planelles G., Dellis O., Gerard B.,
RA   Hulin P., Benque-Blanchet F., Silve C., Grandchamp B., Friedlander G.;
RT   "Nephrolithiasis and osteoporosis associated with hypophosphatemia
RT   caused by mutations in the type 2a sodium-phosphate cotransporter.";
RL   N. Engl. J. Med. 347:983-991(2002).
RN   [7]
RP   VARIANT FRTS2 ILE-LEU-VAL-THR-VAL-LEU-VAL-160 INS, AND
RP   CHARACTERIZATION OF VARIANT FRTS2 ILE-LEU-VAL-THR-VAL-LEU-VAL-160 INS.
RX   PubMed=20335586; DOI=10.1056/NEJMoa0905647;
RA   Magen D., Berger L., Coady M.J., Ilivitzki A., Militianu D.,
RA   Tieder M., Selig S., Lapointe J.Y., Zelikovic I., Skorecki K.;
RT   "A loss-of-function mutation in NaPi-IIa and renal Fanconi's
RT   syndrome.";
RL   N. Engl. J. Med. 362:1102-1109(2010).
CC   -!- FUNCTION: Involved in actively transporting phosphate into cells
CC       via Na(+) cotransport in the renal brush border membrane. Probably
CC       mediates 70-80% of the apical influx.
CC       {ECO:0000269|PubMed:26047794, ECO:0000269|PubMed:8327470}.
CC   -!- SUBUNIT: Interacts via its C-terminal region with PDZK2 (By
CC       similarity). Interacts with SLC9A3R1 (PubMed:22506049).
CC       {ECO:0000250|UniProtKB:Q60825, ECO:0000269|PubMed:22506049}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:26047794}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q06495-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q06495-2; Sequence=VSP_042311;
CC   -!- TISSUE SPECIFICITY: Kidney and lung.
CC   -!- DISEASE: Nephrolithiasis/osteoporosis, hypophosphatemic, 1
CC       (NPHLOP1) [MIM:612286]: A disease characterized by decreased renal
CC       phosphate absorption, renal phosphate wasting, hypophosphatemia,
CC       hyperphosphaturia, hypercalciuria, nephrolithiasis and
CC       osteoporosis. {ECO:0000269|PubMed:12324554}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Fanconi renotubular syndrome 2 (FRTS2) [MIM:613388]: A
CC       disease due to a generalized dysfunction of the proximal kidney
CC       tubule resulting in decreased solute and water reabsorption.
CC       Patients have polydipsia and polyuria with phosphaturia,
CC       glycosuria and aminoaciduria. They may develop hypophosphatemic
CC       rickets or osteomalacia, acidosis and a tendency toward
CC       dehydration. Some eventually develop renal insufficiency.
CC       {ECO:0000269|PubMed:20335586}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Hypercalcemia, infantile, 2 (HCINF2) [MIM:616963]: An
CC       autosomal recessive form of hypercalcemia, a disorder
CC       characterized by abnormally high level of calcium in the blood,
CC       failure to thrive, vomiting, dehydration, and nephrocalcinosis.
CC       {ECO:0000269|PubMed:26047794}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the SLC34A transporter family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L13258; AAA36354.1; -; mRNA.
DR   EMBL; AK298299; BAG60555.1; -; mRNA.
DR   EMBL; AC145098; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS4418.1; -. [Q06495-1]
DR   CCDS; CCDS54953.1; -. [Q06495-2]
DR   PIR; B48189; B48189.
DR   RefSeq; NP_001161051.1; NM_001167579.1. [Q06495-2]
DR   RefSeq; NP_003043.3; NM_003052.4. [Q06495-1]
DR   UniGene; Hs.936; -.
DR   ProteinModelPortal; Q06495; -.
DR   BioGrid; 112457; 1.
DR   STRING; 9606.ENSP00000321424; -.
DR   TCDB; 2.A.58.1.5; the phosphate:na(+) symporter (pnas) family.
DR   iPTMnet; Q06495; -.
DR   PhosphoSitePlus; Q06495; -.
DR   BioMuta; SLC34A1; -.
DR   DMDM; 730113; -.
DR   PaxDb; Q06495; -.
DR   PeptideAtlas; Q06495; -.
DR   PRIDE; Q06495; -.
DR   Ensembl; ENST00000324417; ENSP00000321424; ENSG00000131183. [Q06495-1]
DR   Ensembl; ENST00000512593; ENSP00000423022; ENSG00000131183. [Q06495-2]
DR   GeneID; 6569; -.
DR   KEGG; hsa:6569; -.
DR   UCSC; uc003mgk.5; human. [Q06495-1]
DR   CTD; 6569; -.
DR   DisGeNET; 6569; -.
DR   GeneCards; SLC34A1; -.
DR   HGNC; HGNC:11019; SLC34A1.
DR   HPA; HPA051255; -.
DR   MalaCards; SLC34A1; -.
DR   MIM; 182309; gene.
DR   MIM; 612286; phenotype.
DR   MIM; 613388; phenotype.
DR   MIM; 616963; phenotype.
DR   neXtProt; NX_Q06495; -.
DR   OpenTargets; ENSG00000131183; -.
DR   Orphanet; 244305; Dominant hypophosphatemia with nephrolithiasis or osteoporosis.
DR   Orphanet; 3337; Primary Fanconi syndrome.
DR   PharmGKB; PA35887; -.
DR   eggNOG; ENOG410IE8P; Eukaryota.
DR   eggNOG; COG1283; LUCA.
DR   GeneTree; ENSGT00390000005032; -.
DR   HOGENOM; HOG000006550; -.
DR   HOVERGEN; HBG079110; -.
DR   InParanoid; Q06495; -.
DR   KO; K14683; -.
DR   OMA; CPYGEVL; -.
DR   OrthoDB; EOG091G0DR5; -.
DR   PhylomeDB; Q06495; -.
DR   TreeFam; TF313981; -.
DR   Reactome; R-HSA-427589; Type II Na+/Pi cotransporters.
DR   Reactome; R-HSA-5683826; Surfactant metabolism.
DR   SignaLink; Q06495; -.
DR   GeneWiki; Sodium/phosphate_cotransporter; -.
DR   GenomeRNAi; 6569; -.
DR   PRO; PR:Q06495; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000131183; -.
DR   CleanEx; HS_SLC17A2; -.
DR   CleanEx; HS_SLC34A1; -.
DR   ExpressionAtlas; Q06495; baseline and differential.
DR   Genevisible; Q06495; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005903; C:brush border; IBA:GO_Central.
DR   GO; GO:0031526; C:brush border membrane; ISS:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005768; C:endosome; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031982; C:vesicle; IBA:GO_Central.
DR   GO; GO:0030165; F:PDZ domain binding; IEA:Ensembl.
DR   GO; GO:0032403; F:protein complex binding; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0015321; F:sodium-dependent phosphate transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005436; F:sodium:phosphate symporter activity; IBA:GO_Central.
DR   GO; GO:1901684; P:arsenate ion transmembrane transport; IEA:Ensembl.
DR   GO; GO:0030643; P:cellular phosphate ion homeostasis; IBA:GO_Central.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0071248; P:cellular response to metal ion; IEA:Ensembl.
DR   GO; GO:0071374; P:cellular response to parathyroid hormone stimulus; IEA:Ensembl.
DR   GO; GO:0072734; P:cellular response to staurosporine; IEA:Ensembl.
DR   GO; GO:0097187; P:dentinogenesis; IEA:Ensembl.
DR   GO; GO:1901128; P:gentamycin metabolic process; IEA:Ensembl.
DR   GO; GO:0009100; P:glycoprotein metabolic process; IEA:Ensembl.
DR   GO; GO:0042431; P:indole metabolic process; IEA:Ensembl.
DR   GO; GO:0001822; P:kidney development; IEA:Ensembl.
DR   GO; GO:0001503; P:ossification; IEA:Ensembl.
DR   GO; GO:0055062; P:phosphate ion homeostasis; IDA:UniProtKB.
DR   GO; GO:0006817; P:phosphate ion transport; IDA:UniProtKB.
DR   GO; GO:0045838; P:positive regulation of membrane potential; IEA:Ensembl.
DR   GO; GO:2000187; P:positive regulation of phosphate transmembrane transport; IEA:Ensembl.
DR   GO; GO:2000120; P:positive regulation of sodium-dependent phosphate transport; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
DR   GO; GO:0046686; P:response to cadmium ion; IDA:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0060416; P:response to growth hormone; IEA:Ensembl.
DR   GO; GO:0010288; P:response to lead ion; IDA:UniProtKB.
DR   GO; GO:0032026; P:response to magnesium ion; IEA:Ensembl.
DR   GO; GO:0046689; P:response to mercury ion; IDA:UniProtKB.
DR   GO; GO:0035864; P:response to potassium ion; IEA:Ensembl.
DR   GO; GO:0097066; P:response to thyroid hormone; IEA:Ensembl.
DR   GO; GO:0033189; P:response to vitamin A; IEA:Ensembl.
DR   GO; GO:0072350; P:tricarboxylic acid metabolic process; IEA:Ensembl.
DR   InterPro; IPR003841; Na/Pi_transpt.
DR   InterPro; IPR029848; Na/Pi_transpt_2A.
DR   PANTHER; PTHR10010; PTHR10010; 1.
DR   PANTHER; PTHR10010:SF41; PTHR10010:SF41; 1.
DR   Pfam; PF02690; Na_Pi_cotrans; 2.
DR   TIGRFAMs; TIGR01013; 2a58; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disease mutation; Disulfide bond; Glycoprotein; Ion transport;
KW   Membrane; Phosphoprotein; Reference proteome; Sodium;
KW   Sodium transport; Symport; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    639       Sodium-dependent phosphate transport
FT                                protein 2A.
FT                                /FTId=PRO_0000068607.
FT   TOPO_DOM      1    103       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    104    125       Helical; Name=M1. {ECO:0000255}.
FT   TOPO_DOM    126    145       Extracellular. {ECO:0000255}.
FT   TRANSMEM    146    163       Helical; Name=M2. {ECO:0000255}.
FT   TOPO_DOM    164    165       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    166    185       Helical; Name=M3. {ECO:0000255}.
FT   TOPO_DOM    186    347       Extracellular. {ECO:0000255}.
FT   TRANSMEM    348    370       Helical; Name=M4. {ECO:0000255}.
FT   TOPO_DOM    371    412       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    413    436       Helical; Name=M5. {ECO:0000255}.
FT   TOPO_DOM    437    466       Extracellular. {ECO:0000255}.
FT   TRANSMEM    467    487       Helical; Name=M6. {ECO:0000255}.
FT   TOPO_DOM    488    513       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    514    534       Helical; Name=M7. {ECO:0000255}.
FT   TOPO_DOM    535    539       Extracellular. {ECO:0000255}.
FT   TRANSMEM    540    561       Helical; Name=M8. {ECO:0000255}.
FT   TOPO_DOM    562    639       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES      14     14       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q06496}.
FT   MOD_RES      34     34       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q60825}.
FT   MOD_RES     508    508       Phosphothreonine; by PKC. {ECO:0000255}.
FT   MOD_RES     607    607       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q06496}.
FT   MOD_RES     623    623       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q60825}.
FT   MOD_RES     625    625       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q60825}.
FT   CARBOHYD    298    298       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    323    323       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    330    330       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    225    522       {ECO:0000250}.
FT   DISULFID    306    336       {ECO:0000250}.
FT   VAR_SEQ     313    639       APTSMSRAEANSSQTLGNATMEKCNHIFVDTGLPDLAVGLI
FT                                LLAGSLVLLCTCLILLVKMLNSLLKGQVAKVIQKVINTDFP
FT                                APFTWVTGYFAMVVGASMTFVVQSSSVFTSAITPLIGLGVI
FT                                SIERAYPLTLGSNIGTTTTAILAALASPREKLSSAFQIALC
FT                                HFFFNISGILLWYPVPCTRLPIRMAKALGKRTAKYRWFAVL
FT                                YLLVCFLLLPSLVFGISMAGWQVMVGVGTPFGALLAFVVLI
FT                                NVLQSRSPGHLPKWLQTWDFLPRWMHSLKPLDHLITRATLC
FT                                CARPEPRSPPLPPRVFLEELPPATPSPRLALPAHHNATRL
FT                                -> QNLEGREITHFDLRKKQAMEDSSVPHCP (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042311.
FT   VARIANT      48     48       A -> F (in NPHLOP1; causes
FT                                hypophosphatemic urolithiasis; requires 2
FT                                nucleotide substitutions; results in
FT                                lower phosphate current, decreases
FT                                affinity for phosphate and decreases
FT                                phosphate uptake compared to wild-type;
FT                                shows a dominant-negative effect;
FT                                dbSNP:rs121918610).
FT                                {ECO:0000269|PubMed:12324554}.
FT                                /FTId=VAR_024765.
FT   VARIANT      91     97       Missing (in HCINF2; no change in
FT                                phosphate transport activity; changed
FT                                localization to the apical plasma
FT                                membrane; partial retention inside the
FT                                cell). {ECO:0000269|PubMed:26047794}.
FT                                /FTId=VAR_077913.
FT   VARIANT     147    147       V -> M (in NPHLOP1; causes
FT                                hypophosphatemic osteoporosis; results in
FT                                lower phosphate current, decreases
FT                                affinity for phosphate and decreases
FT                                phosphate uptake compared to wild-type;
FT                                shows a dominant-negative effect;
FT                                dbSNP:rs121918611).
FT                                {ECO:0000269|PubMed:12324554}.
FT                                /FTId=VAR_024766.
FT   VARIANT     153    153       G -> A (in HCINF2; loss of phosphate
FT                                transport activity; loss of localization
FT                                to apical plasma membrane; display a
FT                                complete intracellular retention and no
FT                                detectable actin colocalization).
FT                                {ECO:0000269|PubMed:26047794}.
FT                                /FTId=VAR_077914.
FT   VARIANT     153    153       G -> V (in HCINF2; loss of phosphate
FT                                transport activity; loss of localization
FT                                to apical plasma membrane; display a
FT                                complete intracellular retention and no
FT                                detectable actin colocalization;
FT                                dbSNP:rs769409705).
FT                                {ECO:0000269|PubMed:26047794}.
FT                                /FTId=VAR_077915.
FT   VARIANT     155    155       L -> P (in HCINF2; loss of phosphate
FT                                transport activity; loss of localization
FT                                to apical plasma membrane; display a
FT                                complete intracellular retention and no
FT                                detectable actin colocalization;
FT                                dbSNP:rs369770760).
FT                                {ECO:0000269|PubMed:26047794}.
FT                                /FTId=VAR_077916.
FT   VARIANT     160    160       V -> VILVTVLV (in FRTS2; loss of function
FT                                in the homozygous state).
FT                                {ECO:0000269|PubMed:20335586}.
FT                                /FTId=VAR_063812.
FT   VARIANT     215    215       R -> W (in HCINF2; dbSNP:rs577273266).
FT                                {ECO:0000269|PubMed:26047794}.
FT                                /FTId=VAR_077917.
FT   VARIANT     336    336       C -> G (in HCINF2; loss of phosphate
FT                                transport activity; loss of localization
FT                                to apical plasma membrane; display a
FT                                complete intracellular retention and no
FT                                detectable actin colocalization).
FT                                {ECO:0000269|PubMed:26047794}.
FT                                /FTId=VAR_077918.
FT   VARIANT     408    408       V -> E (in HCINF2; loss of phosphate
FT                                transport activity; loss of localization
FT                                to apical plasma membrane; a complete
FT                                intracellular retention and no detectable
FT                                actin colocalization; dbSNP:rs140649226).
FT                                {ECO:0000269|PubMed:26047794}.
FT                                /FTId=VAR_077919.
FT   VARIANT     488    488       W -> R (in HCINF2; loss of phosphate
FT                                transport activity; loss of localization
FT                                to apical plasma membrane; display a
FT                                complete intracellular retention and no
FT                                detectable actin colocalization).
FT                                {ECO:0000269|PubMed:26047794}.
FT                                /FTId=VAR_077920.
SQ   SEQUENCE   639 AA;  68937 MW;  65D21D968C35D61B CRC64;
     MLSYGERLGS PAVSPLPVRG GHVMRGTAFA YVPSPQVLHR IPGTSAYAFP SLGPVALAEH
     TCPCGEVLER HEPLPAKLAL EEEQKPESRL VPKLRQAGAM LLKVPLMLTF LYLFVCSLDM
     LSSAFQLAGG KVAGDIFKDN AILSNPVAGL VVGILVTVLV QSSSTSTSII VSMVSSGLLE
     VSSAIPIIMG SNIGTSVTNT IVALMQAGDR TDFRRAFAGA TVHDCFNWLS VLVLLPLEAA
     TGYLHHITRL VVASFNIHGG RDAPDLLKII TEPFTKLIIQ LDESVITSIA TGDESLRNHS
     LIQIWCHPDS LQAPTSMSRA EANSSQTLGN ATMEKCNHIF VDTGLPDLAV GLILLAGSLV
     LLCTCLILLV KMLNSLLKGQ VAKVIQKVIN TDFPAPFTWV TGYFAMVVGA SMTFVVQSSS
     VFTSAITPLI GLGVISIERA YPLTLGSNIG TTTTAILAAL ASPREKLSSA FQIALCHFFF
     NISGILLWYP VPCTRLPIRM AKALGKRTAK YRWFAVLYLL VCFLLLPSLV FGISMAGWQV
     MVGVGTPFGA LLAFVVLINV LQSRSPGHLP KWLQTWDFLP RWMHSLKPLD HLITRATLCC
     ARPEPRSPPL PPRVFLEELP PATPSPRLAL PAHHNATRL
//
